vs
R F INDUSTRIES LTD(RFIL)与SUTRO BIOPHARMA, INC.(STRO)财务数据对比。点击上方公司名可切换其他公司
R F INDUSTRIES LTD的季度营收约是SUTRO BIOPHARMA, INC.的1.9倍($22.7M vs $11.6M),R F INDUSTRIES LTD同比增速更快(22.9% vs -21.4%),过去两年R F INDUSTRIES LTD的营收复合增速更高(29.8% vs -5.4%)
妥思卷工业是一家总部位于美国伊利诺伊州芝加哥的糖果制造商,旗下最知名的产品包括同名的Tootsie Roll软糖以及Tootsie Pop棒棒糖,目前其品牌产品销往加拿大、墨西哥等全球超过75个国家。
Sutro Biopharma是一家上市生物科技公司,总部位于加州南旧金山,专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台,结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology,2009年改用现名。
RFIL vs STRO — 直观对比
营收规模更大
RFIL
是对方的1.9倍
$11.6M
营收增速更快
RFIL
高出44.3%
-21.4%
两年增速更快
RFIL
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $22.7M | $11.6M |
| 净利润 | $173.0K | — |
| 毛利率 | 36.8% | — |
| 营业利润率 | 4.0% | — |
| 净利率 | 0.8% | — |
| 营收同比 | 22.9% | -21.4% |
| 净利润同比 | 172.7% | 35.4% |
| 每股收益(稀释后) | $0.01 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RFIL
STRO
| Q4 25 | $22.7M | $11.6M | ||
| Q3 25 | $19.8M | $9.7M | ||
| Q2 25 | $18.9M | $63.7M | ||
| Q1 25 | $19.2M | $17.4M | ||
| Q4 24 | $18.5M | $14.8M | ||
| Q3 24 | $16.8M | $8.5M | ||
| Q2 24 | $16.1M | $25.7M | ||
| Q1 24 | $13.5M | $13.0M |
净利润
RFIL
STRO
| Q4 25 | $173.0K | — | ||
| Q3 25 | $392.0K | $-56.9M | ||
| Q2 25 | $-245.0K | $-11.5M | ||
| Q1 25 | $-245.0K | $-76.0M | ||
| Q4 24 | $-238.0K | $-72.4M | ||
| Q3 24 | $-705.0K | $-48.8M | ||
| Q2 24 | $-4.3M | $-48.0M | ||
| Q1 24 | $-1.4M | $-58.2M |
毛利率
RFIL
STRO
| Q4 25 | 36.8% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 29.8% | — | ||
| Q4 24 | 31.3% | — | ||
| Q3 24 | 29.5% | — | ||
| Q2 24 | 29.9% | — | ||
| Q1 24 | 24.5% | — |
营业利润率
RFIL
STRO
| Q4 25 | 4.0% | — | ||
| Q3 25 | 3.6% | -499.9% | ||
| Q2 25 | 0.6% | -5.2% | ||
| Q1 25 | 0.3% | -393.8% | ||
| Q4 24 | 0.5% | -440.7% | ||
| Q3 24 | -2.5% | -797.2% | ||
| Q2 24 | -2.6% | -189.4% | ||
| Q1 24 | -15.5% | -435.0% |
净利率
RFIL
STRO
| Q4 25 | 0.8% | — | ||
| Q3 25 | 2.0% | -586.6% | ||
| Q2 25 | -1.3% | -18.0% | ||
| Q1 25 | -1.3% | -436.6% | ||
| Q4 24 | -1.3% | -489.2% | ||
| Q3 24 | -4.2% | -572.6% | ||
| Q2 24 | -26.7% | -186.8% | ||
| Q1 24 | -10.1% | -447.5% |
每股收益(稀释后)
RFIL
STRO
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.04 | $-0.67 | ||
| Q2 25 | $-0.02 | $-0.14 | ||
| Q1 25 | $-0.02 | $-0.91 | ||
| Q4 24 | $-0.02 | $-27.63 | ||
| Q3 24 | $-0.07 | $-0.59 | ||
| Q2 24 | $-0.41 | $-0.59 | ||
| Q1 24 | $-0.13 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.2M | $-132.5M |
| 总资产 | $73.0M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
RFIL
STRO
| Q4 25 | $5.1M | $141.4M | ||
| Q3 25 | $3.0M | $167.6M | ||
| Q2 25 | $3.6M | $205.1M | ||
| Q1 25 | $1.3M | $249.0M | ||
| Q4 24 | $839.0K | $316.9M | ||
| Q3 24 | $1.8M | $388.3M | ||
| Q2 24 | $1.4M | $375.6M | ||
| Q1 24 | $4.5M | $267.6M |
股东权益
RFIL
STRO
| Q4 25 | $35.2M | $-132.5M | ||
| Q3 25 | $34.8M | $-87.3M | ||
| Q2 25 | $34.2M | $-32.1M | ||
| Q1 25 | $34.2M | $-25.8M | ||
| Q4 24 | $34.1M | $44.6M | ||
| Q3 24 | $34.1M | $111.2M | ||
| Q2 24 | $34.6M | $152.2M | ||
| Q1 24 | $38.7M | $98.0M |
总资产
RFIL
STRO
| Q4 25 | $73.0M | $173.8M | ||
| Q3 25 | $73.2M | $209.7M | ||
| Q2 25 | $72.7M | $262.4M | ||
| Q1 25 | $70.4M | $321.4M | ||
| Q4 24 | $71.0M | $387.2M | ||
| Q3 24 | $71.9M | $451.8M | ||
| Q2 24 | $72.8M | $489.0M | ||
| Q1 24 | $79.1M | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $2.1M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | — |
| 自由现金流率自由现金流/营收 | 9.0% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 12.13× | — |
| 过去12个月自由现金流最近4个季度 | $4.3M | — |
8季度趋势,按日历期对齐
经营现金流
RFIL
STRO
| Q4 25 | $2.1M | $-177.2M | ||
| Q3 25 | $-311.0K | $-38.2M | ||
| Q2 25 | $2.2M | $-44.7M | ||
| Q1 25 | $601.0K | $-67.9M | ||
| Q4 24 | $-244.0K | $-71.7M | ||
| Q3 24 | $2.4M | $-64.5M | ||
| Q2 24 | $197.0K | $9.5M | ||
| Q1 24 | $840.0K | $-64.7M |
自由现金流
RFIL
STRO
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-419.0K | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $574.0K | — | ||
| Q4 24 | $-418.0K | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $28.0K | — | ||
| Q1 24 | $697.0K | — |
自由现金流率
RFIL
STRO
| Q4 25 | 9.0% | — | ||
| Q3 25 | -2.1% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 5.2% | — |
资本支出强度
RFIL
STRO
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 1.1% | — |
现金转化率
RFIL
STRO
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
STRO
暂无分部数据